Hemostat is a surgical tool used to control bleeding in the surgical process. Hemostats are used by means of tissue sealants and tissue adhesion agents. These products are nowadays replacing conventional sutures for wound and incision closure. The tissue adhesives, tissue sealants, and related products has advantages such as application of minimal invasion, better visualization, reduced operating time, prevention of leakage of non-blood fluids and reduced post-operative infection risks and hence reduction in hospital stays and overall medical costs.

Rise in healthcare insurance providers, technological advancement and growing number of surgery procedures are expected to drive the growth of the market in the coming years. Rise in the untapped emerging nations and increased initiatives take up by governments is expected to offer growth opportunities for the manufacturers operating in the market during the forecast period.

The "Global Hemostats Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global hemostats market trend. The report aims to provide an overview of global hemostats market with detailed market segmentation by product, end user and geography. The global hemostats market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the hemostats market.

The global hemostats market is segmented on the basis of product and end user. Based on product, the hemostats market is categorized as, thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats. On the basis on end user, the hemostats market is segmented as, hospitals & clinics, ambulatory surgical centers and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hemostats market based on product and end user. It also provides market size and forecast till 2025 for overall hemostats market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America dominated the global hemostats market due to the increase in number of surgical procedures, technological advancements. However, the market in Asia-Pacific is anticipated to grow with the fastest rate during the forecast period due to increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key hemostats manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Johnson & Johnson Services, Inc., C. R. Bard, Inc., Baxter, B. Braun Melsungen Ag, Pfizer Inc., Vascular Solutions, Inc., Gelita Medical Gmbh, Integra Lifesciences Holdings Corporation, Equimedical B.V., and Z-Medica, LLC among others.